Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements

Download results of this page

Refine by:


Australia (1)
Austria (4)
Belgium (14)
Burkina Faso (1)
Czech Republic (2)
Denmark (6)
Finland (9)
France (15)
Gabon (1)
Germany (21)
Hungary (1)
Ireland (3)
Italy (14)
Luxembourg (5)
Netherlands (20)
Norway (1)
Poland (1)
Senegal (1)
Slovenia (2)
Spain (10)
Sweden (11)
Switzerland (10)
United Kingdom (25)
United States (7)


English (60)

Advanced search

Results 1 - 10 of 62
12 3 4 5 6 7 > 
Rheuma Tolerance for Cure
[PROJECT] RTCure - Rheuma Tolerance for Cure
ID: 777357
Start date: 2017-09-01, End date: 2022-08-31
In line with IMI2 goals for improved therapies and precision medicine, the aim of this proposal is to prevent and treat RA or its progression by inhibiting maturation/expansion of pathogenic autoimmune responses through immune tolerising treatments of subjects not only in...
Programme: H2020-EU.
Record Number: 211964
Last updated on: 2017-08-29
Development of a translational research project for the induction and monitoring of immune tolerance in Rheumatic Diseases: Rheumatoid Arthritis (RA). Autoimmune diseases affect approximately 5% of the population of Europe, with two-thirds of the patients being female. If...
Record Number: 702226
The scope of the action includes the development and validation of a sustainable governance model for the evaluation of type/brand-specific seasonal influenza vaccine effectiveness in Europe, through collaboration between public and private partners. Furthermore, the scope of...
Record Number: 702224
Starting with a first pilot project focused on Neuroscience and Safety, the goal is to advance the quality and efficiency of Discovery R&D data. This action should provide evidence/data to develop quality criteria for new and/or improved preclinical tests, develop...
Record Number: 702225
The scope is to identify critical mechanism(s) by which ApoE4 leads to the development of AD to build the basis for future development of treatment approaches and supporting biomarkers for ApoE4-positive patients. Research will seek to understand how ApoE4 leads to AD and not...
Record Number: 702427
The scope is to understand:The utility of β-amyloid imaging in the context of other biomarkers and diagnostic tests in current clinical practise in AD.The use of β-amyloid imaging in the enrichment of preclinical/pre-dementia clinical trial populations and its incorporation...
Record Number: 702426
The objectives are to identify and validate candidate biomarkers and/or biomarker panels from existing longitudinal databases. Enhance the understanding of key driver pathways that accelerate progression of DKD, as well as pathways that enable & drive the pathogenesis of...
Record Number: 702422
Objectives (restricted scope is expected for Phase 1) to establish multiple key regional project sites (demonstration sites) across Europe to identify and test models of efficient earlier identification of mild AD dementia and prodromal AD patients, and awareness of AD risk;...
Record Number: 702428
To identify druggable points of interaction in the TREM2 and CD33-signalling pathways to modulate microglial/macrophage function for the treatment of AD, focusing on in vitro, in vivo methodologies using comprehensive analysis tools and pathway/systems biology approaches to...
Record Number: 702425
To establish recommendations with the view of supporting the development of guidance for industry, regulators and health technology assessment (HTA) bodies on how and when in the product life-cycle to consider patient perspectives on benefits and risks of medicinal products to...
Record Number: 702420
12 3 4 5 6 7 > 
List retrieved on: 2017-10-23
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top